Characterization of pathogenic germline mutations in human Protein Kinases

BMC Bioinformatics

Volumn 12, Issue SUPPL. 4, 2011, Pages

  Izarzugaza, Jose M G ^a,b   Hopcroft, Lisa E M ^b   Baresic, Anja ^b   Orengo, Christine A ^b   Martin, Andrew C R ^b   Valencia, Alfonso ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID COMPOSITIONS; CANCER DEVELOPMENT; CELL CYCLE REGULATION; PATHOGENIC MUTATION; PATHOGENIC PROTEINS; PROTEIN FUNCTIONS; STRUCTURAL EFFECT; SUBSTRATE BINDING;

AMINO ACIDS; DISEASES; ENZYMES; SIGNAL TRANSDUCTION; STRUCTURAL PROPERTIES;

PROTEINS;

NR4A2 PROTEIN, HUMAN; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN KINASE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MUTATION; NEOPLASM; POINT MUTATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

GERM-LINE MUTATION; HUMANS; MODELS, MOLECULAR; NEOPLASMS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; POINT MUTATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 79959941083     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-S4-S1     Document Type: Article

References (41)

1. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998, 8(12):1229-31.
2. Taillon-Miller P, Gu Z, Li Q, Hillier L, Kwok PY. Overlapping genomic sequences: a treasure trove of single-nucleotide polymorphisms. Genome Res 1998, 8(7):748-54. 310751, 9685323.
3. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29:308-11. 10.1093/nar/29.1.308, 29783, 11125122.
4. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-83. 10.1038/nrc1299, 2665285, 14993899.
5. Garber K. The second wave in kinase cancer drugs. Nat Biotechnol 2006, 24(2):127-30. 10.1038/nbt0206-127, 16465146.
6. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2001, 298(5600):1912-1934.
7. Knight JDR, Qian B, Baker D, Kothary R. Conservation, variability and the modeling of active protein kinases. PLoS ONE 2007, 2(10):e982. 10.1371/journal.pone.0000982, 1989141, 17912359.
8. Ubersax JA, Woodbury EL, Quang PN, Paraz M, Blethrow JD, Shah K, Shokat KM, Morgan DO. Targets of the cyclin-dependent kinase Cdk1. Nature 2003, 425(6960):859-64. 10.1038/nature02062, 14574415.
9. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, Jona G, Breitkreutz A, Sopko R, McCartney RR, Schmidt MC, Rachidi N, Lee SJ, Mah AS, Meng L, Stark MJR, Stern DF, Virgilio CD, Tyers M, Andrews B, Gerstein M, Schweitzer B, Predki PF, Snyder M. Global analysis of protein phosphorylation in yeast. Nature 2005, 438(7068):679-84. 10.1038/nature04187, 16319894.
10. Krallinger M, Izarzugaza JMG, Rodriguez-Penagos C, Valencia A. Extraction of human kinase mutations from literature, databases and genotyping studies. BMC Bioinformatics 2009, 10(Suppl 8):S1. 10.1186/1471-2105-10-S8-S1, 20151484.
11. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446(7132):153-8. 10.1038/nature05610, 2712719, 17344846.
12. Wood LD, Parsons DW, Jones S, Lin J, Sjöoblom T, Leary RJ, Shen D, Boca SM, Barber TD, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JKV, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PVK, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318(5853):1108-13. 10.1126/science.1145720, 17932254.
13. Baudot A, Real F, Izarzugaza J, Valencia A. From cancer genomes to cancer models: bridging the gaps. EMBO Rep 2009, 10:359-366. 10.1038/embor.2009.46, 2672900, 19305388.
14. Izarzugaza J, Redfern O, Orengo C, Valencia A. Cancer-associated mutations are preferentially distributed in protein kinase functional sites. Proteins 2009, 77:892-903. 10.1002/prot.22512, 19626714.
15. Hurst J, McMillan L, Porter C, Allen J, Fakorede A, Martin A. The SAAPdb web resource: A large-scale structural analysis of mutant proteins. Hum Mutat 2009, 30:616-624. 10.1002/humu.20898, 19191322.
16. López G, Valencia A, Tress ML. FireDB-a database of functionally important residues from proteins of known structure. Nucleic Acids Res 2007, 35(Database issue):D219-23. 1716728, 17132832.
17. Rausell A, Juan D, Pazos F, Valencia A. Protein interactions and ligand binding: from protein subfamilies to functional specificity. Proc Natl Acad Sci USA 2010, 107(5):1995-2000. 10.1073/pnas.0908044107, 2808218, 20133844.
18. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000, 25(2):153-9. 10.1038/75997, 10835628.
19. Mao C, Zhou M, Uckun FM. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J Biol Chem 2001, 276(44):41435-43. 10.1074/jbc.M104828200, 11527964.
20. Caceres M, Teran CG, Rodriguez S, Medina M. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatr 2008, 8:31. 10.1186/1471-2431-8-31, 2526992, 18700035.
21. Leroy JG, Nuytinck L, Lambert J, Naeyaert JM, Mortier GR. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene. Am J Med Genet A 2007, 143A(24):3144-9. 10.1002/ajmg.a.31966, 18000903.
22. Zankl A, Elakis G, Susman RD, Inglis G, Gardener G, Buckley MF, Roscioli T. Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation. Am J Med Genet A 2008, 146A(2):212-8. 10.1002/ajmg.a.32085, 18076102.
23. Fonseca R, Costa-Lima MA, Cosentino V, Orioli IM. Second case of Beare-Stevenson syndrome with an FGFR2 Ser372Cys mutation. Am J Med Genet A 2008, 146A(5):658-60. 10.1002/ajmg.a.32176, 18247426.
24. Torkamani A, Schork NJ. Distribution analysis of nonsynonymous polymorphisms within the human kinase gene family. Genomics 2007, 90:49-58. 10.1016/j.ygeno.2007.03.006, 17498919.
25. Krishnan VG, Westhead DR. A comparative study of machine-learning methods to predict the effects of single nucleotide polymorphisms on protein function. Bioinformatics 2003, 19(17):2199-209. 10.1093/bioinformatics/btg297, 14630648.
26. Vitkup D, Sander C, Church GM. The amino-acid mutational spectrum of human genetic disease. Genome Biol 2003, 4(11):R72. 10.1186/gb-2003-4-11-r72, 329120, 14611658.
27. Wang Z, Moult J. SNPs, protein structure, and disease. Hum Mutat 2001, 17(4):263-70. 10.1002/humu.22, 11295823.
28. Ferrer-Costa C, Orozco M, de la Cruz X. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J Mol Biol 2002, 315(4):771-86. 10.1006/jmbi.2001.5255, 11812146.
29. Ferrer-Costa C, Orozco M, de la Cruz X. Sequence-based prediction of pathological mutations. Proteins 2004, 57(4):811-9. 10.1002/prot.20252, 15390262.
30. Yue P, Li Z, Moult J. Loss of protein structure stability as a major causative factor in monogenic disease. J Mol Biol 2005, 353(2):459-73. 10.1016/j.jmb.2005.08.020, 16169011.
31. Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, Flanagan A, Teague J, Wooster R, Futreal PA, Stratton MR. COSMIC 2005. Br J Cancer 2006, 94(2):318-22. 10.1038/sj.bjc.6602928, 2361125, 16421597.
32. Manning G, Plowman GD, Hunter T, Sudarsanam S. Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 2002, 27(10):514-20. 10.1016/S0968-0004(02)02179-5, 12368087.
33. Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, Suzek BE, Martin MJ, McGarvey P, Gasteiger E. Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics 2009, 10:136. 10.1186/1471-2105-10-136, 2686714, 19426475.
34. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25(17):3389-402. 10.1093/nar/25.17.3389, 146917, 9254694.
35. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005, 33(Database issue):D514-7. 539987, 15608251.
36. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004, 5:113. 10.1186/1471-2105-5-113, 517706, 15318951.
37. Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Meth Enzymol 2003, 374:461-91.
38. Ezkurdia I, Bartoli L, Fariselli P, Casadio R, Valencia A, Tress ML. Progress and challenges in predicting protein-protein interaction sites. Brief Bioinformatics 2009, 10(3):233-46.
39. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000, 28:235-42. 10.1093/nar/28.1.235, 102472, 10592235.
40. Porter CT, Bartlett GJ, Thornton JM. The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 2004, 32(Database issue):D129-33. 308762, 14681376.
41. Pazos F, Helmer-Citterich M, Ausiello G, Valencia A. Correlated mutations contain information about protein-protein interaction. J Mol Biol 1997, 271(4):511-23. 10.1006/jmbi.1997.1198, 9281423.